WuXi AppTec
AsiaWuXi AppTec raised full-year 2026 guidance and announced acceleration of global capacity expansion following strong H1 performance (H1 revenue up 38.9% YoY to RMB 28.90B; backlog up 25.2% YoY to RMB 66.43B).
curated · 2026-08-04 · context →
WuXi AppTec reported strong H1 2026 results and raised full-year guidance, driven by multiple customers' product successes and expansion of CRDMO service model.
curated · 2026-08-03 · context →
US asset managers including BlackRock have expanded stakes in WuXi AppTec over the past two months, betting on surge in weight-loss drug manufacturing orders to lift first-half earnings.
curated · 2026-07-24 · context →
U.S. Department of Defense is presenting a case to designate WuXi AppTec as a Chinese military company, citing state ownership links and military research connections.
curated · 2026-07-14 · context →
WuXi AppTec selected for 2026 Dow Jones Best-in-Class World Index and achieving top-tier ESG ratings across major frameworks; reflects strengthened global position and sustainability integration
curated · 2026-05-18 · context →
WuXi AppTec achieved record 2025 performance with revenue reaching RMB 45.46 billion (up 21.4% YoY) and adjusted non-IFRS net profit up 41.3% to RMB 14.96 billion, with backlog up 28.8%
curated · 2026-03-23 · context →
